Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2017132601) DRY POWDER INHALER
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2017/132601 International Application No.: PCT/US2017/015486
Publication Date: 03.08.2017 International Filing Date: 27.01.2017
IPC:
A61K 9/00 (2006.01) ,A61M 15/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
M
DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
15
Inhalators
Applicants:
MANNKIND CORPORATION [US/US]; 25134 Rye Canyon Loop, Suite 300 Valencia, CA 91355, US
Inventors:
KINSEY, P. Spencer; US
LAURENZI, Brendan; US
SMUTNEY, Chad, C.; US
ADAMO, Benoit; US
GUARNERI, Joseph; US
Agent:
CULLMAN, Louis, C.; US
GIBSON, H.; US
JOHNSON, B.a.; US
BERGMAN, Glasky, M.; US
NOVAK, B.j.; US
Priority Data:
62/289,09529.01.2016US
Title (EN) DRY POWDER INHALER
(FR) INHALATEUR À POUDRE SÈCHE
Abstract:
(EN) A dry powder inhaler including replaceable cartridges containing a dry powder for local or systemic delivery through the pulmonary tract and lungs is disclosed. The inhalers are used with inhalable dry powders, including medicament formulations comprising active agents for local or systemic delivery and for the treatment of diseases such as, pulmonary hypertension, cardiovascular disease, anaphylaxis, diabetes, obesity, cancer, and other diseases, or symptoms associated with these and other diseases, such as nausea, vomiting, pain and inflammation.
(FR) L'invention concerne un inhalateur à poudre sèche comprenant des cartouches remplaçables contenant une poudre sèche pour une administration locale ou systémique à travers le tractus pulmonaire et les poumons. Les inhalateurs sont utilisés avec des poudres sèches pouvant être inhalées, comprenant des formulations de médicament contenant des agents actifs pour une administration locale ou systémique et pour le traitement de maladies telles que l'hypertension pulmonaire, une maladie cardiovasculaire, l'anaphylaxie, le diabète, l'obésité, le cancer et d'autres maladies, ou des symptômes associés à ces dernières et d'autres maladies, tels que la nausée, les vomissements, une douleur et une inflammation.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
CA3012679AU2017211410SG11201806304PCN108778249EP3407870IL260823
IN201817028202BR112018015444